Vertex Pharmaceuticals Inc.

ESG Needs Attention 2/6
Country:
United States of America
Industry:
Health Care
Climate Performance
ESG data
ESG Targets
  • Vertex Pharmaceuticals Inc. has an ESG strategy that is not related to the SDGs
  • 3 year climate performance is inconsistent: 1 SDiD point
  • ESG data transparency is average: 1 SDiD point
  • Vertex Pharmaceuticals Inc. can improve ESG target setting: 0 SDiD points
Vertex Pharmaceuticals Inc. obtains an ESG needs attention SDiD Score® with 2 out of 6 SDiD points.
Climate Performance
Climate performance trends of the company on selected topics
  • GHG Emissions decreased over the past 3 years.
  • Energy use was not measured over the past 3 years.
ESG targets
Implementing ESG commitments involves identification and setting of clear targets that can be readily measured and reported on to stakeholders.
Vertex Pharmaceuticals Inc. communicates data on 1 ESG targets
Industry benchmark is to report data on 3 ESG targets
Topics on which the company communicates ESG targets.
GHG
ESG data
Communication of ESG performance data form the basis for communicating the ESG strategy progress, informing company stakeholders, redefining and adjusting approaches to ESG.
Vertex Pharmaceuticals Inc. communicates data on 4 ESG topics
Industry benchmark is to report data on 4 ESG topics
Topics on which the company communicates ESG data.
Water
GHG Emissions
Waste
Occ. health
SDG
Vertex Pharmaceuticals Inc. has an ESG strategy that is not related to the SDGs
Absolute data
Company Index Ticker Symbol SDiD Score®GHG emissions (tCO2e)Energy (MWh)Waste (t)Water use (m3/1000 liters)Supplier audits (#)Occupational accident rate
Vertex Pharmaceuticals Inc.
Health Care
S&P 500
VRTX
ESG needs attention
2019 - 13,826
2020 - 13,449
2021 - 13,287
-4%
2019 - No data
2020 - No data
2021 - No data
No data
2019 - No data
2020 - 768
2021 - 1,139
No data
2019 - No data
2020 - 101,050
2021 - 102,500
No data
2019 - No data
2020 - No data
2021 - No data
No data
2019 - 0.49
2020 - 0.23
2021 - 0.21
-57%